The Effect of Vaccines and Booster Doses on Disease Progression and Mortality in Inpatients with COVID-19

Authors : Efraim GÜZEL, Oya BAYDAR TOPRAK

Pages : 130-139

View : 32 | Download : 10

Publication Date : 2023-04-30

Article Type : Research Paper

Abstract :Objective: As of the first months of 2020, vaccination is the most effective method to combat the COVID-19 pandemic, which has become a part of our lives. This study aims to describe the vaccination status of inpatients, the effectiveness of booster vaccine protocols, and the risk factors for intensive care unit insert ignore into journalissuearticles values(ICU); and mortality of COVID-19 patients. Materials and Methods: Our study included 247 patients hospitalized in a tertiary care hospital due to COVID-19. Patients hospitalized for non-COVID-19 reasons were excluded from the study even if the PCR test was positive. Socio-demographic data, clinical and laboratory findings of the participants were recorded using the hospital database and a questionnaire. Patients were divided into groups as mild-moderate-severe disease in terms of disease severity, ward and ICU in terms of hospitalization clinic. According to vaccination status, they were categorized as unvaccinated, Sinovac-based protocols, BioNTech-based protocols and others. Results: Of the 247 patients in the study, 55.1% were male and the mean age was 60 ± 17.26 years. 38.5% of the patients were admitted to the ICU and 9.3% died. It was observed that 38.8% of those admitted to the ICU and 56.5% of those who died were not vaccinated. Being over 65 years of age insert ignore into journalissuearticles values(p=0.008);, being hospitalized for more than 7 days insert ignore into journalissuearticles values(p=0.003);, having a severe illness insert ignore into journalissuearticles values(p=0.002);, having a nervous system disease insert ignore into journalissuearticles values(p=0.005); and having other comorbidities insert ignore into journalissuearticles values(p=0.000);, were significant for ICU admission, whereas disease severity insert ignore into journalissuearticles values(p=0.000); and comorbidities such as hypertension insert ignore into journalissuearticles values(p=0.000);, diabetes mellitus insert ignore into journalissuearticles values(p=0.020); and cardiovascular diseases insert ignore into journalissuearticles values(p=0.000); were found to be risk factors for mortality. Conclusion: The addition of reminder doses, especially the fourth dose, to vaccination protocols may be more beneficial in preventing the need for ICU follow-up, which increases mortality in COVID-19.
Keywords : COVID 19, YBÜ, mortalite, aşılar, BioNTech, Sinovac

ORIGINAL ARTICLE URL